Smoking signature is superior to programmed death-ligand 1 expression in predicting pathological response to neoadjuvant immunotherapy in lung cancer patients

BACKGROUND: There is a paucity of biomarkers that can predict the degree of pathological response [e.g., pathological complete response (pCR) or major response (pMR)] to immunotherapy. Neoadjuvant immunotherapy provides an ideal setting for exploring responsive biomarkers because the pathological re...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Haitang, Ma, Wenyan, Sun, Beibei, Fan, Liwen, Xu, Ke, Hall, Sean R. R., Al-Hurani, Mohammad Faisal, Schmid, Ralph A., Peng, Ren-Wang, Hida, Toyoaki, Wang, Zhexin, Yao, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512473/
https://www.ncbi.nlm.nih.gov/pubmed/34733630
http://dx.doi.org/10.21037/tlcr-21-734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512473/
https://www.ncbi.nlm.nih.gov/pubmed/34733630
http://dx.doi.org/10.21037/tlcr-21-734

Ejemplares similares